HPLC determination of bendrofluazide in capsules

Barnes, A.R. and Nash, S. (1993). HPLC determination of bendrofluazide in capsules. International Journal of Pharmaceutics, 94 (1-3), pp. 231-234.


A high-performance liquid Chromatographie method for the determination of bendrofluazide in extemporaneously prepared 1.25 mg capsules is described. This employs a hexyl reversed-phase column, maintained at ambient temperature. The method is stability-indicating and the mean within-day recovery of bendrofluazide from the capsules was 100.2% (±3.8%, 95% confidence limits).

Publication DOI: https://doi.org/10.1016/0378-5173(93)90028-E
Divisions: Life & Health Sciences > Pharmacy
Uncontrolled Keywords: assay,bendrofluazide,capsules,HPLC,tablets,Pharmaceutical Science
Full Text Link: http://www.scopus.com/inward/record.url?scp=0027164448&partnerID=8YFLogxK
Related URLs:
Published Date: 1993-06-21
Authors: Barnes, A.R.
Nash, S.


Item under embargo

Export / Share Citation


Additional statistics for this record